CYBN
USDCybin Inc. Common Shares
$6.170-0.410 (-6.231%)
Real-time Price
Healthcare
Biotechnology
Canada
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$6.580
High
$6.830
Low
$6.170
Volume
1.59M
Company Fundamentals
Market Cap
332.8M
Industry
Biotechnology
Country
Canada
Trading Stats
Avg Volume
0.74M
Exchange
ASE
Currency
USD
52-Week Range
Low $4.81Current $6.170High $13.88
Related News
BusinessWire
Cybin to Participate at the 2025 Milken Institute Future of Health Summit
- Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 - Cybin Inc. (NYSE:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company
View more
BusinessWire
Cybin Announces Closing of $175 Million Registered Direct Offering
Cybin Inc. (Cboe CA: CYBN) (NYSE:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.